Literature DB >> 15791671

Helicobacter pylori in patients can be killed by visible light.

Robert A Ganz1, Jennifer Viveiros, Aamir Ahmad, Atosa Ahmadi, Ayesha Khalil, M Joshua Tolkoff, Norman S Nishioka, Michael R Hamblin.   

Abstract

BACKGROUND: Helicobacter pylori colonizes the mucus layer of the human stomach and may cause peptic ulcer and adenocarcinoma. Novel antimicrobial approaches are sought due to the occurrence of antibiotic resistance and consequent treatment failure. We report here that H. pylori is susceptible to inactivation by blue light. STUDY DESIGN/
MATERIALS AND METHODS: A controlled, prospective, blinded, trial of endoscopically delivered blue light to eradicate H. pylori in regions of the gastric antrum, in 10 patients between the ages of 21 and 80 who tested positive for H. pylori. Light (405 nm) (40 J/cm2) was delivered to a 1-cm diameter spot in the gastric antrum via optical fiber passed through the endoscope and weighed biopsies were taken from treated and control spots and colonies quantitatively cultured.
RESULTS: Blue light killed 5 logs of bacteria in vitro. The mean reduction in H. pylori colonies per gram tissue between treated and control spots was 91% (7.4+/-4.8 x 10(6) vs. 8.1+/-1.9 x 10(7), two-tailed P < 0.0001). Some patients had reductions approaching 99%. No differences were observed on histological examination of light-treated and control gastric tissue.
CONCLUSION: Blue light phototherapy may represent a novel approach to eradication of H. pylori, particularly, in patients who have failed standard antibiotic treatment. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15791671      PMCID: PMC3071042          DOI: 10.1002/lsm.20161

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  27 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

2.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

3.  In vivo porphyrin fluorescence for Propionibacterium acnes. A characterization of the fluorescing pigments.

Authors:  T B Melø; M Johnsson
Journal:  Dermatologica       Date:  1982-03

4.  Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status.

Authors:  D Y Graham; H M Malaty; D G Evans; D J Evans; P D Klein; E Adam
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

5.  A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study.

Authors:  Peter H Katelaris; Geoffrey M Forbes; Nicholas J Talley; Brendan Crotty
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

6.  Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light.

Authors:  Helena Ashkenazi; Zvi Malik; Yoram Harth; Yeshayahu Nitzan
Journal:  FEMS Immunol Med Microbiol       Date:  2003-01-21

7.  Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies.

Authors:  Clive H Wilder-Smith; Petra Wilder-Smith; Pierre Grosjean; Hubert van den Bergh; Alain Woodtli; Philippe Monnier; Gian Dorta; Friedrich Meister; Georges Wagnières
Journal:  Lasers Surg Med       Date:  2002       Impact factor: 4.025

8.  The effective treatment of acne vulgaris by a high-intensity, narrow band 405-420 nm light source.

Authors:  Monica Elman; Michael Slatkine; Yoram Harth
Journal:  J Cosmet Laser Ther       Date:  2003-06       Impact factor: 2.247

9.  The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections.

Authors:  Brian J McMahon; Thomas W Hennessy; J Michael Bensler; Dana L Bruden; Alan J Parkinson; Julie M Morris; Alisa L Reasonover; Debby A Hurlburt; Michael G Bruce; Frank Sacco; Jay C Butler
Journal:  Ann Intern Med       Date:  2003-09-16       Impact factor: 25.391

10.  Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.

Authors:  Loren Laine; Richard Hunt; Hala El-Zimaity; Bich Nguyen; Michael Osato; Jean Spénard
Journal:  Am J Gastroenterol       Date:  2003-03       Impact factor: 10.864

View more
  32 in total

1.  Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode array.

Authors:  Michelle Maclean; Scott J MacGregor; John G Anderson; Gerry Woolsey
Journal:  Appl Environ Microbiol       Date:  2009-02-06       Impact factor: 4.792

2.  Phototargeting human periodontal pathogens in vivo.

Authors:  Nikolaos S Soukos; Jacyn Stultz; Abraham D Abernethy; J Max Goodson
Journal:  Lasers Med Sci       Date:  2013-12-18       Impact factor: 3.161

3.  Photo Inactivation of Streptococcus mutans Biofilm by Violet-Blue light.

Authors:  Grace F Gomez; Ruijie Huang; Meoghan MacPherson; Andrea G Ferreira Zandona; Richard L Gregory
Journal:  Curr Microbiol       Date:  2016-06-08       Impact factor: 2.188

4.  Ultraviolet A/blue light-emitting diode therapy for vulvovaginal candidiasis: a case presentation.

Authors:  Mariana Robatto; Maria Clara Pavie; Igor Garcia; Manoela Porto Menezes; Milena Bastos; Handerson Jorge Dourado Leite; Andreia Noites; Patrícia Lordelo
Journal:  Lasers Med Sci       Date:  2019-04-03       Impact factor: 3.161

Review 5.  Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes.

Authors:  Domingo Mariano Adolfo Vera; Mark H Haynes; Anthony R Ball; Tianhong Dai; Christos Astrakas; Michael J Kelso; Michael R Hamblin; George P Tegos
Journal:  Photochem Photobiol       Date:  2012-02-13       Impact factor: 3.421

Review 6.  Can light-based approaches overcome antimicrobial resistance?

Authors:  Michael R Hamblin; Heidi Abrahamse
Journal:  Drug Dev Res       Date:  2018-08-02       Impact factor: 4.360

Review 7.  Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?

Authors:  Tianhong Dai; Asheesh Gupta; Clinton K Murray; Mark S Vrahas; George P Tegos; Michael R Hamblin
Journal:  Drug Resist Updat       Date:  2012-07-28       Impact factor: 18.500

8.  Therapy of chronic wounds with water-filtered infrared-A (wIRA).

Authors:  Verena von Felbert; Hauke Schumann; James B Mercer; Wolfgang Strasser; Georg Daeschlein; Gerd Hoffmann
Journal:  GMS Krankenhhyg Interdiszip       Date:  2008-03-05

9.  Blue light kills Aggregatibacter actinomycetemcomitans due to its endogenous photosensitizers.

Authors:  Fabian Cieplik; Andreas Späth; Christoph Leibl; Anita Gollmer; Johannes Regensburger; Laura Tabenski; Karl-Anton Hiller; Tim Maisch; Gottfried Schmalz
Journal:  Clin Oral Investig       Date:  2013-12-03       Impact factor: 3.573

Review 10.  Photodynamic therapy for localized infections--state of the art.

Authors:  Tianhong Dai; Ying-Ying Huang; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2009 Sep-Dec       Impact factor: 3.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.